Therefore, drawing on the development of the Energix‐B vaccine against Hepatitis B, researchers utilized the hepatitis B surface antigen (HBsAg) as a carrier protein for the CSP central repeat region and C‐CSP. This evidence concerns the gene DNAJC5 and hepatitis B virus infection.